Program highlights for the fiscal year ended March 31, 2025, along with recent developments, include: Patient with advanced/metastatic end-stage pancreatic cancer who responded to MDNA11 treatment ...

IL-2 Receptor Antagonists. Recent research has focused on the role of the IL-2 receptor in acute allograft rejection. T-cell proliferation, a central event leading to graft rejection, is triggered ...

Copenhagen, Denmark Friday, June 20, 2025, 15:00 Hrs [IST] ...

Company announcement - No. 15 / 2025 Zealand Pharma announces positive topline results from 28-week Phase 1b trial with GLP-1 ...

Enjoy food trucks, entertainment and even a drone show at this Juneteenth celebration organized by the Peoria Park District.

Citius Oncology inks distribution services agreement with Cardinal Health: Cranford, New Jersey Wednesday, June 11, 2025, 11:00 Hrs [IST] Citius Oncology, Inc. (Citius Oncology), ...

Cis-binding maximizes synergy between immune checkpoint blockade and IL-2R activation on the same CD8⁺ T effector cells for optimal tumor cytotoxicity. MDNA113 retains PD-1/PDL-1 blockade while ...

Title: T cell and Immune Activation from a Phase 1 Study of STK -012, a First-in-class IL-2R α/ß Selective Partial Agonist in Advanced Solid Tumors Session Name: Novel Single-Agent ...

Like the OnePlus Watch 2, the OnePlus Watch 2R comes in one 46mm size, with Bluetooth and Wi-Fi connectivity but no optional LTE cellular support. Measuring 47.0 by 46.6 by 12.1mm (HWD), these are ...